• Je něco špatně v tomto záznamu ?

Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension

T Zelinka, O Petrak, B Strauch, R Holaj, J Kvasnicka, J Mazoch, K Pacak, J Jr Widimsky

. 2007 ; 14 (1) : 57-64.

Jazyk angličtina Země Švýcarsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10013190
E-zdroje Online

NLK Karger Journals od 1994 do 2009

OBJECTIVE: To investigate the effect of long-term catecholamine excess in pheochromocytoma on leukocyte and platelet count and on proteins of acute-phase response. METHODS: Fifteen subjects with pheochromocytoma, 16 with primary aldosteronism, 18 with essential hypertension and 17 healthy controls were studied. Sixteen subjects with pheochromocytoma were investigated after tumor removal. Leukocyte, neutrophil and platelet count, as well as C-reactive protein were measured in all subjects, while fibrinogen, alpha(1)-antitrypsin, alpha(2)-macroglobulin, orosomucoid, transferrin and prealbumin were only measured in subjects with pheochromocytoma, primary aldosteronism and essential hypertension. RESULTS: Subjects with pheochromocytoma showed significantly higher leukocyte [7.5 +/- 0.9 10(9)/l, p < 0.001 vs. primary aldosteronism (5.4 +/- 0.9 10(9)/l) and healthy controls (5 +/- 0.9 10(9)/l), p = 0.04 vs. essential hypertension (6.3 +/- 1.6 10(9)/l)], neutrophil (p < 0.001 vs. primary aldosteronism and healthy subjects) and platelet counts (p < 0.001 vs. primary aldosteronism; p = 0.01 vs. essential hypertension) compared to the other groups of subjects. Similar results were obtained for positive proteins of acute-phase response in subjects with pheochromocytoma [C-reactive protein: 0.62 +/- 0.52 mg/dl, p < 0.001 vs. healthy subjects (0.08 +/- 0.08 mg/dl), p = 0.001 vs. primary aldosteronism (0.17 +/- 0.19 mg/dl), p = 0.04 vs. essential hypertension (0.31 +/- 0.26 mg/dl); fibrinogen: p = 0.02 vs. primary aldosteronism; orosomucoid: p = 0.005 vs. primary aldosteronism; alpha(2)-macroglobulin: p = 0.009 vs. primary aldosteronism]. No significant differences were found in plasma levels of alpha(1)-antitrypsin, transferrin and prealbumin. Tumor removal led to a significant decrease in leukocyte (p = 0.004), neutrophil (p = 0.007) and platelet count (p = 0.003) and also to a significant decrease in acute-phase proteins (C-reactive protein: p = 0.03, fibrinogen: p = 0.008, alpha(1)-antitrypsin: p = 0.003, orosomucoid: p = 0.04). CONCLUSIONS: Chronic catecholamine excess in pheochromocytoma is accompanied by an increase in inflammation markers which was reversed by the tumor removal. Copyright 2007 S. Karger AG, Basel.

000      
04583naa 2200637 a 4500
001      
bmc10013190
003      
CZ-PrNML
005      
20121130125315.0
008      
100602s2007 sz e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Zelinka, Tomáš $7 xx0074465
245    10
$a Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension / $c T Zelinka, O Petrak, B Strauch, R Holaj, J Kvasnicka, J Mazoch, K Pacak, J Jr Widimsky
314    __
$a 3rd Department of Medicine, General Faculty Hospital, Praha, Czech Republic. tzeli@lf1.cuni.cz
520    9_
$a OBJECTIVE: To investigate the effect of long-term catecholamine excess in pheochromocytoma on leukocyte and platelet count and on proteins of acute-phase response. METHODS: Fifteen subjects with pheochromocytoma, 16 with primary aldosteronism, 18 with essential hypertension and 17 healthy controls were studied. Sixteen subjects with pheochromocytoma were investigated after tumor removal. Leukocyte, neutrophil and platelet count, as well as C-reactive protein were measured in all subjects, while fibrinogen, alpha(1)-antitrypsin, alpha(2)-macroglobulin, orosomucoid, transferrin and prealbumin were only measured in subjects with pheochromocytoma, primary aldosteronism and essential hypertension. RESULTS: Subjects with pheochromocytoma showed significantly higher leukocyte [7.5 +/- 0.9 10(9)/l, p < 0.001 vs. primary aldosteronism (5.4 +/- 0.9 10(9)/l) and healthy controls (5 +/- 0.9 10(9)/l), p = 0.04 vs. essential hypertension (6.3 +/- 1.6 10(9)/l)], neutrophil (p < 0.001 vs. primary aldosteronism and healthy subjects) and platelet counts (p < 0.001 vs. primary aldosteronism; p = 0.01 vs. essential hypertension) compared to the other groups of subjects. Similar results were obtained for positive proteins of acute-phase response in subjects with pheochromocytoma [C-reactive protein: 0.62 +/- 0.52 mg/dl, p < 0.001 vs. healthy subjects (0.08 +/- 0.08 mg/dl), p = 0.001 vs. primary aldosteronism (0.17 +/- 0.19 mg/dl), p = 0.04 vs. essential hypertension (0.31 +/- 0.26 mg/dl); fibrinogen: p = 0.02 vs. primary aldosteronism; orosomucoid: p = 0.005 vs. primary aldosteronism; alpha(2)-macroglobulin: p = 0.009 vs. primary aldosteronism]. No significant differences were found in plasma levels of alpha(1)-antitrypsin, transferrin and prealbumin. Tumor removal led to a significant decrease in leukocyte (p = 0.004), neutrophil (p = 0.007) and platelet count (p = 0.003) and also to a significant decrease in acute-phase proteins (C-reactive protein: p = 0.03, fibrinogen: p = 0.008, alpha(1)-antitrypsin: p = 0.003, orosomucoid: p = 0.04). CONCLUSIONS: Chronic catecholamine excess in pheochromocytoma is accompanied by an increase in inflammation markers which was reversed by the tumor removal. Copyright 2007 S. Karger AG, Basel.
650    _2
$a nádory nadledvin $x komplikace $x krev $x patofyziologie $7 D000310
650    _2
$a dospělí $7 D000328
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a C-reaktivní protein $x analýza $7 D002097
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrinogen $x analýza $7 D005340
650    _2
$a lidé $7 D006801
650    _2
$a hyperaldosteronismus $x komplikace $x krev $x patofyziologie $7 D006929
650    _2
$a hypertenze $x etiologie $x krev $7 D006973
650    _2
$a zánět $x komplikace $x krev $7 D007249
650    _2
$a počet leukocytů $7 D007958
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neutrofily $7 D009504
650    _2
$a orosomukoid $x analýza $7 D009961
650    _2
$a feochromocytom $x komplikace $x krev $x patofyziologie $7 D010673
650    _2
$a počet trombocytů $7 D010976
650    _2
$a prealbumin $x analýza $7 D011228
650    _2
$a transferin $x analýza $7 D014168
650    _2
$a alfa-1-antitrypsin $x krev $7 D000515
650    _2
$a alfa-makroglobuliny $x analýza $7 D000511
650    _2
$a financování organizované $7 D005381
700    1_
$a Petrák, Ondřej $7 xx0104500
700    1_
$a Štrauch, Branislav. $7 xx0035015
700    1_
$a Holaj, Robert $7 xx0074140
700    1_
$a Kvasnička, Jan, $d 1943- $7 mzk2003187694
700    1_
$a Mazoch, Jiří. $7 _BN003617
700    1_
$a Pacák, Karel, $d 1958- $7 jo20000074102
700    1_
$a Widimský, Jiří, $d 1956- $7 jn99240001422
773    0_
$t Neuroimmunomodulation $w MED00003488 $g Roč. 14, č. 1 (2007), s. 57-64 $x 1021-7401
910    __
$a ABA008 $b x $y 7
990    __
$a 20110413110753 $b ABA008
991    __
$a 20121130125344 $b ABA008
999    __
$a ok $b bmc $g 749080 $s 612685
BAS    __
$a 3
BMC    __
$a 2007 $b 14 $c 1 $d 57-64 $i 1021-7401 $m Neuroimmunomodulation $n Neuroimmunomodulation $x MED00003488
LZP    __
$a 2010-B2/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...